Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of BOTOX Treatment in Adult Patients with Upper Limb Spasticity
2013-002327-42Phase 3Terminated
- Sponsor
- Allergan
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in Muscle spasm, upper extremity spasticity and neurological diseases (2 arms), sponsored by Allergan. Started Apr 2014; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmupper extremity spasticityneurological diseases
Beyond the preview
Go deeper on 2013-002327-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002327-42.